Physician profile
Faera Byerly
NPI 1568681161
$884.37
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $114 · 2021: $104 · 2022: $164 · 2023: $226 · 2024: $74.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $300.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endomagnetics Ltd | $144.68 | 2023 | Magseed, Magtrace |
| Ethicon US, LLC | $139.61 | 2019-2022 | |
| Heron Therapeutics, INC. | $94.06 | 2022-2024 | Zynrelef |
| Innocoll Pharmaceuticals Limited | $55.98 | 2021-2022 | |
| Smith+Nephew, INC. | $44.40 | 2020-2022 | |
| Asensus Surgical, INC. | $38.61 | 2019 | |
| Kerecis Limited | $35.84 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Bioptics, INC. | $31.38 | 2019-2020 | |
| Organogenesis INC. | $30.90 | 2024 | Puraply Am |
| Acell, INC. | $30.00 | 2019 | |
| Abbvie INC. | $29.67 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.01 | 2021 | |
| Baxter Healthcare | $26.38 | 2019 | |
| Rti Surgical, INC | $24.85 | 2023 | |
| Merck Sharp & Dohme LLC | $24.42 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $20.71 | 2023 | Emprint |
| Atricure, INC. | $18.66 | 2019 | |
| Davol INC. | $18.49 | 2022 | |
| Biom'Up France Sas | $16.88 | 2021 | |
| Cardinal Health 414 LLC | $14.83 | 2019 | |
| Allergan, INC. | $12.45 | 2020 | |
| Aroa Biosurgery Incorporated | $3.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faera Byerly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.